https://www.selleckchem.com/pr....oducts/Sunitinib-Mal
PURPOSE To evaluate outcome data of patients undergoing DeJour sulcus-deepening trochleoplasty with medial patellofemoral ligament reconstruction (MPFLR) for high-grade trochlear dysplasia at a single institution in the United States. METHODS A total of 67 patients (76 knees) with severe trochlear dysplasia and recurrent patellar instability were prospectively enrolled and underwent DeJour sulcus-deepening trochleoplasty with MPFLR from 2011-2019. Inclusion criteria included recurrent lateral patellar instability follo
Like
Comment
Share
